Showing results (461-470 of 633) with videos related to
Sort By:
Pageof 64
European Journal of Clinical Pharmacology|January 1, 1993
Changes in plasma and urinary 11-dehydrothromboxane B2 in healthy subjects produced by oral CS-518, a novel thromboxane synthase inhibitorT Uematsu, W Takasaki, K Kosuge, et al.Peptides|July 1, 1990
Atrial natriuretic peptide messenger RNA and peptide in rats with aortic valve insufficiencyH Morita, I Tanaka, T Oda, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1989
[Intra-arterial injection of cisplatin suspension in lipiodol (LPS) for the treatment of advanced hepatocellular carcinoma (stage IV)]J Shibata, S Kimura, M Nakashima, et al.Pathology, Research and Practice|March 9, 2000
Overexpression of Ets-1 transcription factor in angiosarcoma of the skinS Naito, K Shimizu, M Nakashima, et al.Research Communications in Chemical Pathology and Pharmacology|March 1, 1989
Arterial-venous plasma concentration differences of 6-chloro-2-pyridylmethyl nitrate in humans after sublingual administrationT Terada, K Ishibashi, T Tsuchiya, et al.Biological & Pharmaceutical Bulletin|October 23, 1997
Effects of astemizole on ventricular activation delay and RT intervals in a canine myocardial infarction modelM Nishimoto, H Hashimoto, T Ohmura, et al.Medical Physics|February 24, 2001
Processing of medical images using real-time optical Fourier processingA Panchangam, K V Sastry, D V Rao, et al.Blood|July 4, 2001
Receptor binding cancer antigen expressed on SiSo cells, a novel regulator of apoptosis of erythroid progenitor cellsT Matsushima, M Nakashima, K Oshima, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|October 2, 2001
Controlled release and ocular absorption of tilisolol utilizing ophthalmic insert-incorporated lipophilic prodrugsS Kawakami, K Nishida, T Mukai, et al.Acta Neurochirurgica|February 10, 2006
Analyses of the factors influencing bone graft infection after delayed cranioplastyA Matsuno, H Tanaka, H Iwamuro, et al.Pageof 64